American journal of hematology, 2020-09, Vol.95 (9), p.E235-E238
2020
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study
- Ist Teil von
- American journal of hematology, 2020-09, Vol.95 (9), p.E235-E238
- Ort / Verlag
- Hoboken, USA: John Wiley & Sons, Inc
- Erscheinungsjahr
- 2020
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0361-8609eISSN: 1096-8652DOI: 10.1002/ajh.25864Titel-ID: cdi_proquest_journals_2435494028
- Format
- –
- Schlagworte
- Adolescent, Adult, Aged, Autoimmune diseases, Cytarabine, Cytarabine - administration & dosage, Cytarabine - adverse effects, Disease-Free Survival, Drug Therapy, Combination, Female, Hematology, Histiocytosis, Histiocytosis, Langerhans-Cell - diagnosis, Histiocytosis, Langerhans-Cell - drug therapy, Histiocytosis, Langerhans-Cell - mortality, Humans, Langerhans cell histiocytosis, Male, Methotrexate, Methotrexate - administration & dosage, Methotrexate - adverse effects, Middle Aged, Prospective Studies, Survival Rate